SUBSCRIBE
SUBSCRIBE

Opus Genetics

NEWS
Business
Spark Founders Launch Opus Genetics to Tackle Rare Forms of Blindness
The startup’s initial focus will be on rare blindness conditions affecting pediatric patients.
September 22, 2021
 · 
2 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Press Releases
Opus Genetics Announces One-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseases
April 9, 2025
 · 
13 min read
Press Releases
Opus Genetics Files Definitive Proxy Statement and Sends Letter to Stockholders Highlighting the Company’s Transformation and Progress
April 7, 2025
 · 
12 min read
Press Releases
Opus Genetics to Participate in Upcoming Investor Conference in April
April 2, 2025
 · 
6 min read
Press Releases
Opus Genetics Announces Financial Results for Full Year 2024
April 1, 2025
 · 
20 min read
Press Releases
Opus Genetics Announces Pricing of Public Offering and Concurrent Private Placement with Proceeds of Over $20 Million
March 24, 2025
 · 
9 min read
Press Releases
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 19, 2025
March 20, 2025
 · 
2 min read
Press Releases
Opus Genetics Announces Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
March 5, 2025
 · 
9 min read
Press Releases
Opus Genetics Announces FDA Fast Track and Enrollment Updates for Phentolamine Ophthalmic Solution 0.75% Programs
February 26, 2025
 · 
10 min read
Press Releases
Opus Genetics Announces Updates on OPGx-LCA5 Clinical Program
February 18, 2025
 · 
8 min read
Press Releases
Shareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc.
February 7, 2025
 · 
10 min read
Load More